# Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-of-dabigatran-for-stroke-prevention-in-atrial-fibrillation-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Mark Pletscher,Rafael Plessow,Klaus Eichler,Simon Wieser |
| Citations | 49 |
| DOI | 10.4414/smw.2013.13732 |
| Fields | Economics, Econometrics and Finance,Medicine,Nursing |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://smw.ch/index.php/smw/article/download/1805/2493 |
| OpenAlex ID | https://openalex.org/W2018617209 |
| PMID | 23300013 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Mark Pletscher](https://scholariq.org/researchers/mark-pletscher/)

## Paper primary topic

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)

## Paper topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Vitamin K Research Studies](https://scholariq.org/topics/vitamin-k-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.